Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting neuroinflammation in Alzheimer’s disease
Maria Rosanna Bronzuoli, Aniello Iacomino, Luca Steardo, et al.
Journal of Inflammation Research (2016) Vol. Volume 9, pp. 199-208
Open Access | Times Cited: 217

Showing 26-50 of 217 citing articles:

Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice
Michael S. Unger, P. Schernthaner, Julia Marschallinger, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 103
Pharmacological approaches to mitigate neuroinflammation in Alzheimer’s disease
Md. Sahab Uddin, Md. Tanvir Kabir, Abdullah Al Mamun, et al.
International Immunopharmacology (2020) Vol. 84, pp. 106479-106479
Closed Access | Times Cited: 97
Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis
Charlotte Warren‐Gash, Harriet Forbes, Elizabeth Williamson, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 96
Beneficial Effects of Exercise Pretreatment in a Sporadic Alzheimer’s Rat Model
Chongyun Wu, Luodan Yang, Donovan Tucker, et al.
Medicine & Science in Sports & Exercise (2017) Vol. 50, Iss. 5, pp. 945-956
Open Access | Times Cited: 95
Sex differences in the phagocytic and migratory activity of microglia and their impairment by palmitic acid
Natalia Yanguas‐Casás, Andrea Crespo‐Castrillo, Marı́a L. de Ceballos, et al.
Glia (2017) Vol. 66, Iss. 3, pp. 522-537
Closed Access | Times Cited: 93
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
Amanda Cano, Patric Turowski, Miren Ettcheto, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 87
Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis
Shuai Xiang, Jin-Long Ji, Sha Li, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 48
Gene expression data analysis using Hellinger correlation in weighted gene co-expression networks (WGCNA)
Tianjiao Zhang, Garry Wong
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 3851-3863
Open Access | Times Cited: 39
The effects of resistance exercise on cognitive function, amyloidogenesis, and neuroinflammation in Alzheimer’s disease
Caroline Vieira Azevedo, Debora Hashiguchi, Henrique Correia Campos, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 27
Modulation of Gut Microbiota Through Dietary Intervention in Neuroinflammation and Alzheimer’s and Parkinson’s Diseases
Şerife Ayten, Saniye Bilici
Current Nutrition Reports (2024) Vol. 13, Iss. 2, pp. 82-96
Open Access | Times Cited: 13
Investigating White Matter Neuroinflammation in Alzheimer Disease Using Diffusion-Based Neuroinflammation Imaging
Qing Wang, Suzanne E. Schindler, Gengsheng Chen, et al.
Neurology (2024) Vol. 102, Iss. 4
Closed Access | Times Cited: 11
Slowing Alzheimer’s disease progression through probiotic supplementation
Destynie Medeiros, Kristina McMurry, Melissa R. Pfeiffer, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 10
RETRACTED ARTICLE: Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer’s disease
Panchanan Maiti, Leela Paladugu, Gary Dunbar
BMC Neuroscience (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 82
Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review
Erwin Lemche
Current Genomics (2018) Vol. 19, Iss. 7, pp. 522-602
Open Access | Times Cited: 73
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease
Elham Nasiri, Roman Sankowski, Henriette Dietrich, et al.
Molecular Medicine (2020) Vol. 26, Iss. 1
Open Access | Times Cited: 70
Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer’s Disease
Zhiwei Shen, Xinjie Bao, Renzhi Wang
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 69
Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology
Martina Holubová, Lucie Hrubá, Andrea Popelová, et al.
Neuropharmacology (2018) Vol. 144, pp. 377-387
Closed Access | Times Cited: 67
Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model
Jae J. Song, Sang-Min Oh, Oh‐Chan Kwon, et al.
Journal of Clinical Investigation (2017) Vol. 128, Iss. 1, pp. 463-482
Open Access | Times Cited: 65
Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases
Irene Reyes‐Resina, Gemma Navarro, David Aguinaga, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 169-179
Open Access | Times Cited: 65
The immune system on the TRAIL of Alzheimer’s disease
Chiara Burgaletto, Antonio Munafò, Giulia Di Benedetto, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 64
Traditional Chinese medicine for anti-Alzheimer’s disease: berberine and evodiamine from Evodia rutaecarpa
Zhiling Fang, Yuqing Tang, Jiaming Ying, et al.
Chinese Medicine (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 56
Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer’s Disease
Shahul Hameed, Jong‐Ling Fuh, Vorapun Senanarong, et al.
Journal of Alzheimer s Disease Reports (2020) Vol. 4, Iss. 1, pp. 21-37
Open Access | Times Cited: 52
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease
Feiqi Zhu, Chunrong Li, Fengna Chu, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 52
Mass spectrometry‐based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids
Magdalena Korecka, Leslie M. Shaw
Journal of Neurochemistry (2021) Vol. 159, Iss. 2, pp. 211-233
Open Access | Times Cited: 48
Peripheral inflammatory biomarkers predict the deposition and progression of amyloid-β in cognitively unimpaired older adults
Lauren E. Oberlin, Kirk I. Erickson, Rachel H. Mackey, et al.
Brain Behavior and Immunity (2021) Vol. 95, pp. 178-189
Open Access | Times Cited: 41

Scroll to top